Endothelins (ETs) are potent vasoconstrictive peptides that are secreted by the vascular endothelium and other tissues in vertebrates. Previous studies have demonstrated that ETs are expressed in a variety of fish tissues and contract various blood vessels. In order to determine if receptors for ET are expressed in fish gill tissue, we examined the binding kinetics of 125 I-labeled, human ET-1 to membrane fragments isolated from the gill of the dogfish shark, Squalus acanthias. 125 I-ET-1 bound at a single site, with a dissociation constant (Kd) and binding site number (Bmax) very similar to those described in a variety of mammalian blood vessels. ET-1 and ET-3 competed equally with 125 I-ET-1, suggesting that the receptor was ETB, which has been shown in mammalian systems to bind to both ligands equally. The ETB-specific agonists sarafotoxin S6c, IRL-1620, and BQ-3020 also competed against 125 I-ET-1 at a single site, supporting this hypothesis. We conclude that the shark gill expresses an ETB receptor with substantial homology to the mammalian receptor and that ET may play an important role in modulating such vital gill functions as gas exchange, ion regulation, acid–base balance, and excretion of nitrogen.

The endothelins (ETs) are considered to be the most potent vasoconstrictive agents in animals (e.g. Tamirisa et al., 1995). In addition to cardiovascular effects, it is now clear that ETs play a role in the function of many organs, including the pituitary, kidney and adrenal gland (e.g. Kennedy et al., 1993; Masaki, 1993). ET-1 was first isolated from endothelial cells, but ET-1 and the other members of the peptide family, ET-2 and ET-3, have been described from many tissues including the intestine, stomach, heart, kidney and brain of mammals (e.g. Masaki, 1993; Stjernquist, 1998).

The effects of the endothelins are mediated through at least two receptors, termed ETA and ETB, differentiated by their relative specificity for agonists and antagonists. ETA is much more sensitive to ET-1 than to either ET-2 or ET-3 and it is blocked by the inhibitor BQ-123. ETB is equally sensitive to all three ETs, and to the analogue sarafotoxin S6c (SRX S6c; originally isolated from the venom of the snake Atractaspis engaddrnsis) and various linear analogues of ET-1 (such as Ac-[Ala11,15 ]endothelin-1 (6-21), termed BQ-3020; and Suc-[Glu9, Ala11,15 ]endothelin-1 (8-21), termed IRL-1620) (e.g. Huggins et al., 1993; Hiley, 1995). In mammals, ETA receptors mediate the constrictory effect of ET on the vascular smooth muscle, although in some vessels, especially veins but also various arteries, constriction may be mediated via the ETB receptors (e.g. Sumner et al., 1992; Pollock and Opgenorth, 1993; Warner et al., 1993; Sudjarwo et al., 1994; Teerlink et al., 1994; White et al., 1994). More commonly, ETB receptors mediate the initial, transitory dilation produced by infusion of ET-1 (Spokes et al., 1989), which is now known to involve an autocrine action of ET on endothelial cells, stimulating the release of the endothelium-derived relaxing factor, nitric oxide (De Nucci et al., 1988; Rubanyi and Polokoff, 1994). In fact, there is some suggestion that distinct ETB receptors, termed ETB1 and ETB2, may mediate dilation versus constriction, respectively (e.g. Warner et al., 1993; Bax and Saxena, 1994; Sudjarwo et al., 1994; Teerlink et al., 1994; Zuccarello et al., 1998a), although this hypothesis is not universally accepted (e.g. Clozel and Gray, 1995).

There is an emerging literature demonstrating that ET and its receptors are present in fish tissues, but little is known about the physiology of endothelin in this group. Immunoreactive ET has been localized in the brain of the lamprey, Lampetra japonica, and the caudal neurosecretory system, gill and kidney of the teleost, Oryzias latipes (medaka) (Kasuya et al., 1991) as well as the gills of the Indian catfish (Heteropneustes fossilis), brown trout (Salmo trutta), electric ray (Torpedo marmorata), dogfish shark (Scyliorhinus canicula) and bowfin (Amia calva) (Zaccone et al., 1996). In addition, ET-1 constricted various blood vessels (e.g. ventral aorta, coronary artery, mesenteric artery, posterior cardinal vein or celiacomesenteric artery) from the catfish (Amiurus melas) (Poder et al., 1991), rainbow trout (Oncorhynchus mykiss) (Olson et al., 1991), Atlantic salmon (Salmo salar) and cod (Gadus morhua) (Sverdrup et al., 1994) and S. acanthias (Evans et al., 1996). We have also recently determined that the ventral aortae of the lamprey (Petromyzon marinus), Atlantic hagfish (Myxine glutinosa), Florida gar (Lepisosteus platyrhynchus), gulf toadfish (Opsanus beta), American eel (Anguilla rostrata) and African lungfish (Protopterus aethiopicus) constrict when ET-1 is applied (D. H. Evans, unpublished). It is clear, therefore, that at least vascular receptors for ET arose before the earliest vertebrates. Indeed, immunoreactive ET has been described in the nervous system of invertebrates (Kasuya et al., 1991). In all but one of the functional studies in fishes, the specific ET receptor was not delineated; however, we determined that an ETB receptor mediates the constrictory response in the ventral aorta of S. acanthias (Evans et al., 1996).

The fish gill is a structurally complex organ that plays a vital role in such important processes as gas exchange, ion regulation, acid–base regulation and excretion of nitrogenous waste products (e.g. Evans, 1998). We have previously shown that the gills of various species (M. glutinosa, S. acanthias and O. beta) express receptors for natriuretic peptides (Donald et al., 1994, 1997; Toop et al., 1995), although the precise location of the receptors (vascular versus epithelial) is still unknown. To begin to access the role of endothelins in fish gill function, we have characterized ET binding to membrane fragments isolated from the gill of the dogfish shark, S. acanthias.

Adult spiny dogfish Squalus acanthias (L.) (3–5 kg) were netted in Frenchman Bay, Maine, USA and maintained in live cars with running sea water (12–15 °C) at the Mount Desert Island Biological Laboratory (Salsbury Cove, ME, USA) for at least 24 h before use. Fish were killed by pithing through the snout, and gills were removed and frozen immediately in liquid N2. The tissue was stored at –70 °C before shipment to the University of Florida on dry ice.

Membrane fragments were prepared as described previously (e.g. Donald et al., 1997). Gill tissue was scraped off the gill arch and homogenized in 3–5 volumes of buffer (50 mmol l−1 Tris-HCl, 1 mmol l−1 NaHCO3, pH 7.4 at room temperature (RT); 24 °C) using a Tissue-Tearor (Biospec, Bartlesville, OK, USA). The homogenate was diluted 1:1 with a buffer solution containing 50 mmol l−1 Tris-HCl, 1 mmol l−1 EDTA and 1 mmol l−1 MgCl2 (pH 7.4), and centrifuged at 800 g for 15 min at 4 °C. The supernatant was poured through three layers of cheesecloth into a second tube and spun at 30,000 g for 20 min at 4 °C. This supernatant was discarded, and the pellet was washed with a solution of 50 mmol l−1 Tris-HCl and 250 mmol l−1 sucrose (pH 7.4 at RT) and resuspended in the same solution (250–500 μl). A subsample was taken for protein analysis (BCA Protein Assay Kit, Pierce), the rest subdivided and stored at –70 °C until use.

For the kinetic analysis of the binding of 125 I-ET-1 to a putative membrane receptor, 50 μg of gill protein was incubated at RT in 250 μl of a buffer solution [50 mmol l−1 Tris-HCl, 100 mmol l−1 NaCl, 5 mmol l−1 MgCl2, 0.25 % bovine serum albumin, 0.05 % Bacitracin, 4 μg ml−1 Leupeptin, 2 μg ml−1 Chymostatin, 2 μg ml−1 Pepstatin and 1 μg ml−1 phenylmethyl-sulfonyl fluoride (PMFS) and 10−12 –10−6 mol l−12 1 125 I-ET-1 (Peninsula Laboratories, Belmont, CA, USA)]. Preliminary experiments determined that 90 min incubation was sufficient for maximal binding. Non-specific binding was measured by including 10−6 mol l−1 ET-1 in a separate set of incubation tubes containing the incubation buffer, gill protein and concentration range of radiolabeled ET-1. For competition assays, the same protocol was used, except that each reaction tube contained 30 pmol l−1 125 I-ET-1 and specific concentrations of either unlabelled ET-1 or putative competitive agonists or antagonists for either ETA or ETB receptors. In all experiments, binding was terminated by addition of 2 ml of ice-cold 50 mmol l−1 Tris-HCl and 100 mmol l−1 NaCl (pH 7.4), and bound and free ligand were separated by vacuum filtration through a Whatman GF/C filter, pretreated with 1 % polyethylenimine. The filters were then washed with 5 ml of the ice-cold washing buffer, placed in glass vials and assayed on a Beckman gamma counter with 78 % efficiency.

ET-1 (human) and ET-3 (human) were purchased from American Peptide (Sunnyvale, CA) and dissolved in 1 % acetic acid, divided into portions, evaporated to dryness (SpeedVac; Savant, Framingdale, NY, USA) and stored at –70 °C until use. SRX S6c, BQ-3020, IRL-1620 and RES-701-1 (Gly-Asn-Trp-His-Gly-Thr-Ala-Pro-Asp-Trp-Phe-Phe-Asn-Tyr-Tyr-Trp) were also purchased from American Peptide, dissolved in 5 % dimethylsulfoxide (DMSO) and portions stored at –70 °C until use. Maximal DMSO concentration in the final reaction solution was 0.05 %. All data analysis (non-linear regression for saturation and competitive binding, and Student’s t-test) used Prism (GraphPad, Inc., San Diego, CA, USA). Data are expressed as mean ± S.E.M.

125 I-ET-1 binding to shark gill membranes was saturable, with an apparent dissociation constant Kd of 68.8±10.9 pmol l−1 and a binding site number Bmax of 780±59.7 fmol mg−1 protein (N=3), calculated by non-linear regression (Fig. 1). In all three binding experiments, non-linear regression equations for one-versus two-site models were tested using Prism; in every case, the single-site equation provided the best fit. The Scatchard analysis (Fig. 1) also indicated a single binding site.

Fig. 1.

Representative saturation binding curve of 125 I-ET-1 to gill membranes from Squalus acanthias. Inset: Scatchard analysis of the binding data.

Fig. 1.

Representative saturation binding curve of 125 I-ET-1 to gill membranes from Squalus acanthias. Inset: Scatchard analysis of the binding data.

Unlabeled ET-1 competed with 125 I-ET-1 at a single site with a 50% inhibition constant IC50 of 5.11±0.99 nmol l−1 (N=10; Fig. 2A). The inhibitor constant Ki was calculated to be 3.57±0.69 nmol l−1, using the method of Cheng and Prusoff (1973). ET-3 also competed with 125 I-ET-1 at a single site with an IC50 of 8.93±4.90 nmol l−1 (N=6; Fig. 2B), not significantly different from the IC50 of ET-1 (P=0.4). The ETB-specific agonists SRX S6c, IRL-1620 and BQ-3020 also displaced the radiolabeled ET-1 (Fig. 3AC) with high efficacy: IC50=1.77±1.31 nmol l−1 (N=8), 32.8±18.7 nmol l−1 (N=7) and 37.2±13.5 nmol l−1 (N=7), respectively. All competitions were at a single site. Only the IC50 of BQ-3020 was signficantly above (P<0.001) that of ET-1. The ETB-specific antagonist RES-701-1 did not compete with 125 I-ET-1 until relatively high concentrations (producing a 15 % reduction in specific binding at 3×10−7 mol l−1 and 50 % reduction at 10−6 mol l−1 RES-701-1; data not shown).

Fig. 2.

Plot of competition between unlabeled human ET-1 (A) or ET-3 (B) and 125 I-ET-1 for binding to gill membranes. Data were normalized so that maximal competition (zero binding of 125 I-ET-1) was assumed to be at 10−6 mol l−1 unlabelled ET-1 or ET-3. Values are means ± S.E.M.; N=7–11 for ET-1 and 6–7 for ET-3; the curves were fitted by eye.

Fig. 2.

Plot of competition between unlabeled human ET-1 (A) or ET-3 (B) and 125 I-ET-1 for binding to gill membranes. Data were normalized so that maximal competition (zero binding of 125 I-ET-1) was assumed to be at 10−6 mol l−1 unlabelled ET-1 or ET-3. Values are means ± S.E.M.; N=7–11 for ET-1 and 6–7 for ET-3; the curves were fitted by eye.

Fig. 3.

Plot of competition between SRX S6c (A, N=8-9), IRL 1620 (B, N=7) and BQ-3020 (C, N=6-7) and 125 I-ET-1 for binding to gill membranes. Data were normalized so that maximal competition (zero binding of 125 I-ET-1) was assumed to be at 10−6 mol l−1 for each agonist. Values are meams ± S.E.M.

Fig. 3.

Plot of competition between SRX S6c (A, N=8-9), IRL 1620 (B, N=7) and BQ-3020 (C, N=6-7) and 125 I-ET-1 for binding to gill membranes. Data were normalized so that maximal competition (zero binding of 125 I-ET-1) was assumed to be at 10−6 mol l−1 for each agonist. Values are meams ± S.E.M.

These data provide the first pharmacological characterization of an endothelin receptor in a fish gill, or any tissue in a fish. They suggest that there is a single endothelin receptor expressed (Fig. 1), with kinetic characteristics (Kd, Bmax) quite similar to those described for the binding of ET-1 to mammalian vascular endothelin receptors (Table 1). Since a heterologous ligand was used (human ET-1), it is clear that the fish gill ET receptor must share significant homology with the mammalian receptor. The fact that ET-3 is as competitive as ET-1 at the single site (Fig. 2) suggests that the gill receptor is an ETB, because that is the promiscous receptor that binds to all native ligands equally (e.g. Huggins et al., 1993; Masaki et al., 1994). This hypothesis is supported by our finding that three ETB-specific receptor agonists (SRX S6c, IRL-1620 and BQ-3020; e.g. Masaki et al., 1994) each competed with 125 I-ET-1 at a single site with a relatively low IC50, equivalent to that for ET-1 in each case except for BQ-3020 (Fig. 3). In the rat aorta and atrium (in which ETA is the predominant receptor expressed), ET-1 is 50 000 times more potent than SRX S6c in displacing 125 I-ET-1 (Williams et al., 1991). IRL-1620 has an ETB/ETA selectivity of 120 000 in binding experiments (Takai et al., 1992), but BQ-3020 has a lower ratio of selectivity (4700; Saeki et al., 1991). Our data are also consistent with our previous study (Evans et al., 1996), which demonstrated that the ET-1-induced contraction of the ventral aorta from S. acanthias was mediated by a single receptor with nearly equivalent sensitivity to ET-1, ET-3 and SRX S6c and no sensitivity to BQ-123, the well-described ETA-specific antagonist (e.g. Ihara et al., 1992).

Table 1.

Published kinetic characteristics of endothelin receptors in mammalian blood vessels

Published kinetic characteristics of endothelin receptors in mammalian blood vessels
Published kinetic characteristics of endothelin receptors in mammalian blood vessels

Although the hypothesis that the ETB receptors which mediate dilation (termed ETB1) are distinct from the ETB receptors that mediate contraction (termed ETB2; e.g. Stjernquist, 1998) is not universally accepted (e.g. Clozel and Gray, 1995), many studies have demonstrated differences in the sensitivity of ETB receptors to specific agonists and antagonists. It has been suggested that the putative ETB1 receptor is sensitive to the agonist IRL-1620 and the antagonist RES-701-1 (e.g. Sudjarwo et al., 1994; Brooks et al., 1995; Zuccarello et al., 1998b), while the ETB2 receptor is insensitive to either substance. The receptor in the shark gill was extremely sensitive to IRL-1620 (Fig. 3), but the putative ETB1 receptor antagonist, RES-701-1, showed little or no competition with 125 I-ET-1. In addition, our earlier physiological studies demonstrated that RES-701-1 did not inhibit the ET-1 stimulated contraction of aortic rings from this species (D. H. Evans and M. P. Gunderson, unpublished data). These data suggest that the shark ETB receptor shares characteristics with both the putative ETB1 and ETB2 receptors that have been proposed for mammals (e.g. Stjernquist, 1998).

Our data do not allow us to delineate specific sites for the ETB receptor in the S. acanthias gill, but two recent studies (Sundin and Nilsson, 1998; Stenslokken et al., 1999) have demonstrated that ET receptors may produce a redistribution of blood flow within the gill lamellae of the rainbow trout (O. mykiss) and Atlantic cod (G. morhua) by constriction of pillar cells. In their experiments, ET-1 increased blood flow to the periphery of the lamellae, which presumably alters the epithelial surface area for gas exchange or passive movements of ions. Whether ET receptors are expressed on pillar cells or in microvessels in the shark gill remains to be determined, as does its putative role in gill hemodynamics.

Gill ET receptors also may play a role in controlling other gill functions, such as osmoregulation, acid–base regulation and nitrogen excretion. ET-1 has been shown to stimulate Na+ -K+ -activated ATPase in both the rat adrenal zona glomerulosa (Pecci et al., 1994) and cerebral capillary endothelium (Kawai et al., 1995); but it inhibited this enzyme in inner medullary collecting duct cells in the kidney of the rabbit (Zeidel et al., 1989). However, ET-1 did not affect the activity of Na+ -K+ -activated ATPase in rabbit colonic mucosa (Roden et al., 1992). ET-1 stimulated Na+ -K+ -Cl transport (Vigne, 1994; Kawai et al., 1995) and Na+ /H+ exchange (Vigne et al., 1991) in the rat cerebral capillary endothelium as well as a Cl channel in the rat colonic mucosa (Hosokawa et al., 1995). It also inhibited influx of Na+ through an apical, amiloride-sensitive channel in the colonic mucosa (Hosokawa et al., 1995). ET-1, however, inhibited both Na+ /H+ exchange and V-type H+ pump activity in cultured bovine corneal epithelial cells (Wu et al., 1998). The transport mechanisms whereby Na+ and Cl cross the epithelium of the fish gill are well characterized, especially in the teleosts, and there is functional evidence that all of these proteins that have been shown to be affected by ET-1 are expressed and mediate various pathways for NaCl extrusion or uptake (depending on the salinity) as well as acid–base regulation (see Evans et al., 1999). It is likely, therefore, that ET may play a role in gill solute transport as well as gill hemodynamics. In fact, our preliminary data (D. H. Evans and K. J. Karnaky, unpublished) suggest that both ET-1 and SRX S6c inhibit the short-circuit current, dose-dependently, across the opercular skin from the killifish, Fundulus heteroclitus, which is the standard model for salt extrusion by the marine teleost gill (e.g. Karnaky, 1998).

This work was supported by NSF grants IBN-9306997 and IBN-9604824 and American Heart Association (Maine Affiliate) grant 9507715S to D.H.E., as well as NIEHS grant P30-ESO3238 to the Center for Membrane Toxicity Studies at the Mount Desert Island Biological Laboratory.

Bax
,
W. A.
and
Saxena
,
P. R.
(
1994
).
The current endothelin receptor classification: time for reconsideration?
Trends Pharmacol. Sci
.
15
,
379
386
.
Brooks
,
D. P.
,
DePalma
,
P. D.
,
Pullen
,
M.
,
Gellai
,
M.
and
Nambi
,
P.
(
1995
).
Identification and function of putative ETB receptor subtypes in the dog kidney
.
J. Cardiovasc. Pharmacol
.
26
,
S322
325
.
Cheng
,
Y.
and
Prusoff
,
W. H.
(
1973
).
Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
.
Biochem. Pharmacol
.
22
,
3099
3108
.
Clozel
,
M.
and
Gray
,
G. A.
(
1995
).
Are there different ETB receptors mediating constriction and relaxation?
J. Cardiovasc. Pharmacol
.
26
,
S262
264
.
Davenport
,
A. P.
,
O’Reilly
,
G.
and
Kuc
,
R. E.
(
1995
).
Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type
.
Br. J. Pharmacol
.
114
,
1110
1116
.
De Leon
,
H.
and
Garcia
,
R.
(
1995
).
Characterization of endothelin receptor subtypes in isolated rat renal preglomerular microvessels
.
Regul. Pept
.
60
,
1
8
.
De Nucci
,
G.
,
Thomas
,
R.
,
D-Orleans-Juste
,
P.
,
Antunes
,
E.
,
Walder
,
C.
,
Warner
,
T. D.
and
Vane
,
J. R.
(
1988
).
Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of protacyclin and endothelium-derived relaxing factor
.
Proc. Natl. Acad. Sci. USA
85
,
9797
9800
.
Donald
,
J. A.
,
Toop
,
T.
and
Evans
,
D. H.
(
1994
).
Localization and analysis of natriuretic peptide receptors in the gills of the gulf toadfish, Opsanus beta
.
Am. J. Physiol
.
267
,
R1437
R1444
.
Donald
,
J. A.
,
Toop
,
T.
and
Evans
,
D. H.
(
1997
).
Distribution and characterization of natriuretic peptide receptors in the gills of the spiny dogfish, Squalus acanthias
.
Gen. Comp. Endocrinol
.
106
,
338
347
.
Edwards
,
R. M.
and
Trizna
,
W.
(
1995
).
Characterization of 125 I-endothelin-1 binding to rat and rabbit renal microvasculature
.
J. Pharmacol. Exp. Ther
.
274
,
1084
1089
.
Evans
,
D. H.
(
1998
).
The Physiology of Fishes
, pp.
519
.
Boca Raton
:
CRC Press
.
Evans
,
D. H.
,
Gunderson
,
M.
and
Cegelis
,
C.
(
1996
).
ETB-type receptors mediate endothelin-stimulated contraction in the aortic vascular smooth muscle of the spiny dogfish shark, Squalus acanthias
.
J. Comp. Physiol
.
165
,
659
664
.
Evans
,
D. H.
,
Piermarini
,
P. M.
and
Potts
,
W. T. W.
(
1999
).
Ionic transport in the fish gill epithelium
.
J. Exp. Zool
.
283
,
641
652
.
Hiley
,
C. R.
(
1995
).
Endothelin receptor ligands
.
Neurotransmissions
11
,
1
6
.
Hosokawa
,
M.
,
Tsukada
,
H.
,
Ueda
,
S.
,
Sakai
,
M.
,
Okuma
,
M.
,
Oda
,
K.
,
Takimoto
,
M.
,
Okada
,
T.
and
Urade
,
Y.
(
1995
).
Regulation of ion transport by endothelins in rat colonic mucosa: effects of an ETA antagonist (FR139317) and an ETB agonist (IRL1620)
.
J. Pharmacol. Exp. Ther
.
273
,
1313
1322
.
Huggins
,
J. P.
,
Pelton
,
J. T.
and
Miller
,
R. C.
(
1993
).
The structure and specificity of endothelin receptors: Their importance in physiology and medicine
.
Pharmacol. Ther
.
59
,
55
123
.
Ihara
,
M.
,
Noguchi
,
K.
,
Saeki
,
T.
,
Fukuroda
,
T.
,
Tsuchida
,
S.
,
Kimura
,
S.
,
Fukami
,
T.
,
Ishikawa
,
K.
,
Nishikibe
,
M.
and
Yano
,
M.
(
1992
).
Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor
.
Life Sci
.
50
,
247
255
.
Karnaky
,
K. J.
, Jr
. (
1998
).
Osmotic and Ionic Regulation
.
In The Physiology of Fishes
(ed.
D. H.
Evans
), pp.
157
176
.
Boca Raton
:
CRC Press
.
Kasuya
,
Y.
,
Kobayashi
,
H.
and
Uemura
,
H.
(
1991
).
Endothelin-like immunoreactivity in the nervous system of invertebrates and fish
.
J. Cardiovasc. Pharmacol
.
17
,
S463
466
.
Kawai
,
N.
,
Yamamoto
,
T.
,
Yamamoto
,
H.
,
McCarron
,
R. M.
and
Spatz
,
M.
(
1995
).
Endothelin 1 stimulates Na(+), K(+) -ATPase and Na(+) -K(+) -Cl(−) cotransport through ETA receptors and protein kinase C-dependent pathway in cerebral capillary endothelium
.
J. Neurochem
.
65
,
1588
1596
.
Kennedy
,
R. L.
,
Haynes
,
W. G.
and
Webb
,
D. J.
(
1993
).
Endothelins as regulators of growth and function in endocrine tissues
.
Clin. Endocrinol
.
39
,
259
265
.
Masaki
,
T.
(
1993
).
Endothelins: Homeostatic and compensatory actions in the circulatory and endocrine systems
.
Endocrinol. Rev
.
14
,
256
268
.
Masaki
,
T.
,
Vane
,
J. R.
and
Vanhoutte
,
P. M.
(
1994
).
V. International Union of Pharmacology nomenclature of endothelin receptors
.
Pharmacol. Rev
.
46
,
137
142
.
Olson
,
K. R.
,
Duff
,
D. W.
,
Farrell
,
A. P.
,
Keen
,
J.
,
Kellogg
,
M. D.
,
Kullman
,
D.
and
Villa
,
J.
(
1991
).
Cardiovascular effects of endothelin in trout
.
Am. J. Physiol
.
260
,
H1214
H1223
.
Pecci
,
A.
,
Cozza
,
E. N.
,
Devlin
,
M.
,
Gomez-Sanchez
,
C. E.
and
Gomez-Sanchez
,
E. P.
(
1994
).
Endothelin-1 stimulation of aldosterone and zona glomerulosa ouabain-sensitive sodium/potassium-ATPase
.
J. Steroid. Biochem. Mol. Biol
.
50
,
49
53
.
Pollock
,
D. M.
and
Opgenorth
,
T. J.
(
1993
).
Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation
.
Am. J. Physiol
.
264
,
R222
R226
.
Poder
,
T. C.
,
Silberberg
,
S. D.
and
Rampe
,
D.
(
1991
).
Contraction of reptile, amphibian, and fish blood vessels by endothelin-1
.
Can. J. Physiol. Pharmacol
.
69
,
215
217
.
Roden
,
M.
,
Plass
,
H.
,
Vierhapper
,
H.
and
Turnheim
,
K.
(
1992
).
Endothelin-1 stimulates chloride and potassium secretion in rabbit descending colon
.
Pflugers Arch
.
421
,
163
167
.
Rubanyi
,
G. M.
and
Polokoff
,
M. A.
(
1994
).
Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology
.
Pharmacol. Rev
.
46
,
325
415
.
Saeki
,
T.
,
Ihara
,
M.
,
Fukuroda
,
T.
,
Yamagiwa
,
M.
and
Yano
,
M.
(
1991
).
[Ala1,3,11,15 ]endothelin-1 analogs with ETB agonistic activity
.
Biochem. Biophys. Res. Commun
.
179
,
285
292
.
Spokes
,
R. A.
,
Ghatei
,
M. A.
and
Bloom
,
S. R.
(
1989
).
Studies with endothelin 3 and endothelin 1 on rat blood pressure and isolated tissues: evidence for multiple endothelin receptor subtypes
.
J. Cardiovasc. Pharamcol
.
13
(
Suppl. 5
),
S191
192
.
Stenslokken
,
K. O.
,
Sundin
,
L.
and
Nilsson
,
G. E.
(
1999
).
Cardiovascular and gill microcirculatory effects of endothelin-1 in Atlantic cod: evidence for pillar cell contraction
.
J. Exp. Biol
.
202
,
1151
1157
.
Stjernquist
,
M.
(
1998
).
Endothelins – vasoactive peptides and growth factors
.
Cell Tissue. Res
.
292
,
1
9
.
Sudjarwo
,
S. A.
,
Hori
,
M.
,
Tanaka
,
T.
,
Matsuda
,
Y.
,
Okada
,
T.
and
Karaki
,
H.
(
1994
).
Subtypes of endothelin ETA and ETB receptors mediating venous smooth muscle contraction
.
Biochem. Biophys. Res. Commun
.
200
,
627
633
.
Sundin
,
L.
and
Nilsson
,
G. E.
(
1998
).
Endothelin redistributes blood flow through the lamellae of rainbow trout gills: evidence for pillar cell contraction
.
J. Comp. Physiol. B
168
,
619
623
.
Sumner
,
M. J.
,
Cannon
,
T. R.
,
Mundin
,
J. W.
,
White
,
D. G.
and
Watts
,
I. S.
(
1992
).
Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction
.
Br. J. Pharmacol
.
107
,
858
860
.
Sverdrup
,
A.
,
Krüger
,
P. G.
and
Helle
,
K. B.
(
1994
).
Role of the endothelium in regulation of vascular functions in two teleosts
.
Acta Physiol. Scand
.
152
,
219
233
.
Takai
,
M.
,
Umemura
,
I.
,
Yamasaki
,
K.
,
Watakabe
,
T.
,
Fujitani
,
Y.
,
Oda
,
K.
,
Urade
,
Y.
,
Inui
,
T.
,
Yamamura
,
T.
and
Okada
,
T.
(
1992
).
A potent and specific agonist, Suc-[Glu9, Ala11,15 ] endothelin 1 (8–21), IRL 1620, for the ETB receptor
.
Biochem. Biophys. Res. Commun
.
184
,
953
959
.
Tamirisa
,
P.
,
Frishman
,
W. H.
and
Kumar
,
A.
(
1995
).
Endothelin and endothelin antagonism: Roles in cardiovascular health and disease
.
Am. Heart J
.
130
,
601
610
.
Teerlink
,
J. R.
,
Breu
,
V.
,
Sprecher
,
U.
,
Clozel
,
M.
and
Clozel
,
J. P.
(
1994
).
Potent vasoconstriction mediated by endothelin ETB receptors in canine coronary arteries
.
Circ. Res
.
74
,
105
114
.
Toop
,
T.
,
Donald
,
J. A.
and
Evans
,
D. H.
(
1995
).
Localisation and characteristics of natriuretic peptide receptors in the gills of the Atlantic hagfish, Myxine glutinosa (Agnatha)
.
J. Exp. Biol
.
198
,
117
126
.
Vigne
,
P.
,
Farre
,
A. L.
and
Frelin
,
C.
(
1994
).
Na+ -K+ -Cl cotransporter of brain capillary endothelial cells: properties and regulation by endothelins hyperosmolar solutions, calcyculinA, and interleukin-1
.
J. Biol. Chem
.
269
,
19925
19930
.
Vigne
,
P.
,
Ladoux
,
A.
and
Frelin
,
C.
(
1991
).
Endothelins activate Na+ /H+ exchange in brain capillary endothelial cells via a high affinity endothelin-3 receptor that is not coupled to phospholipase C
.
J. Biol. Chem
.
266
,
5925
5928
.
Warner
,
T. D.
,
Allcock
,
G. H.
,
Mickley
,
E. J.
,
Corder
,
R.
and
Vane
,
J. R.
(
1993
).
Comparative studies with the endothelin receptor antagonists BQ-123 and PD 142893 indicate at least three endothelin receptors
.
J. Cardiovasc. Pharmacol
.
22
,
S117
S120
.
White
,
D. G.
,
Garratt
,
H.
,
Mundin
,
J. W.
,
Sumner
,
M. J.
,
Vallance
,
P. J.
and
Watts
,
I. S.
(
1994
).
Human saphenous vein contains both endothelin ETA and ETB contractile receptors
.
Eur. J. Pharmacol
.
257
,
307
310
.
Williams
,
D. L.
, Jr.
,
Jones
,
K. L.
,
Pettibone
,
D. J.
,
Lis
,
E. V.
and
Clineschmidt
,
B. V.
(
1991
).
Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes
.
Biochem. Biophys. Res. Commun
.
175
,
556
561
.
Wu
,
X.
,
Torres-zamorano
,
V.
,
Yang
,
H.
and
Reinach
,
P. S.
(
1998
).
ETA receptor-mediated inhibition of intracellular pH regulation in cultured bovine corneal epithelial cells
.
Exp. Eye Res
.
66
,
699
708
.
Yu
,
J. C.
,
Pickard
,
J. D.
and
Davenport
,
A. P.
(
1995
).
Endothelin ETA receptor expression in human cerebrovascular smooth muscle cells
.
Br. J. Pharmacol
.
116
,
2441
2446
.
Zaccone
,
G.
,
Mauceri
,
A.
,
Fasulo
,
S.
,
Ainis
,
L.
,
Lo Cascio
,
P.
and
Ricca
,
M. B.
(
1996
).
Localization of immunoreactive endothelin in the neuroendocrine cells of fish gill
.
Neuropeptides
30
,
53
57
.
Zeidel
,
M. L.
,
Brady
,
H. R.
,
Kone
,
B. C.
,
Gullans
,
S. R.
and
Brenner
,
B. M.
(
1989
).
Endothelin, a peptide inhibitor of Na(+) -K(+) -ATPase in intact renal tubular epithelial cells
.
Am. J. Physiol
.
257
,
C1101
1107
.
Zuccarello
,
M.
,
Boccaletti
,
R.
and
Rapoport
,
R. M.
(
1998a
).
Endothelin ET(B) receptor-mediated constriction in the rabbit basilar artery
.
Eur. J. Pharmacol
.
350
,
R7
9
.
Zuccarello
,
M.
,
Boccaletti
,
R.
and
Rapoport
,
R. M.
(
1998b
).
Endothelin ETB1 receptor-mediated relaxation of rabbit basilar artery
.
Eur. J. Pharmacol
.
357
,
67
71
.